In colorectal cancer liver metastasis, tumor-derived FGF19 acts on FGFR4 expressed in hepatic stellate cells, activating the JAK2–STAT3 pathway and inducing their differentiation into iCAFs. The gene discussed is STAT3; the disease is neoplasm.